TC
APEN

Truvestments Capital’s Apollo Endosurgery, Inc. APEN Stock Holding History

Truvestments Capital’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$0 Buy
+9
New +$70 ﹤0.01% 878

Other funds holding APEN

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Truvestments Capital's APEN Position: Q3 2018 in Review

Truvestments Capital opened a new position in Apollo Endosurgery, Inc. (APEN) in Q3 2018: 9 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #878 among its holdings.

38 funds tracked by Wall St. Rank hold APEN as of Q3 2018.

  • Truvestments Capital held 9 shares of Apollo Endosurgery, Inc. worth $0 as of Q3 2018.
  • Apollo Endosurgery, Inc. was a new Truvestments Capital position in Q3 2018.
  • Apollo Endosurgery, Inc. made up ﹤0.01% of Truvestments Capital's portfolio in Q3 2018, its #878 holding.
  • 38 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2018.

Based on Truvestments Capital's 13F filing for Q3 2018, filed 22 Oct 2018.